ResMed Inc (RMD)
NYSE • Healthcare
July 2, 2026 at 20:00 UTC
About ResMed Inc
ResMed Inc. (NYSE: RMD) makes and markets healthcare devices and connected digital solutions for sleep, respiratory, and out-of-hospital care. The company operates in the medical technology field and generated $5.1 billion in revenue in FY2025. Its business spans device hardware, software, and related services used across clinical and home-based care settings.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ResMed Inc's Technical Indicators Summary
RMD presents a buy-leaning technical picture as recent price action is above the short- and medium-term averages and momentum and CCI readings are strongly positive, with MACD also favoring bulls. However, longer-term moving averages remain higher, indicating a broader downtrend to contend with, and on-balance volume is mixed. ADX is low, so trend conviction is limited and volatility is moderate. Technical takeaway: Buy — short-term momentum and moving-average support outweigh longer-term resistance in the near term.
| Indicator | Value |
|---|---|
RSI (14) | 62.39 |
Stochastic %K (14, 3, 3) | 81.71 |
CCI (20) | 240.94 |
WPR (14) | -0.20 |
Momentum (10) | 23.34 |
MFI | 67.56 |
MACD Level (12, 26) | 0.11 |
Bollinger Bands | $184.80 - $205.39 |
ATR (14) | $5.81 (2.77%) |
ADX (14) | 18.99 |
OBV | -13,965,021 |
Classic Pivot Point | $200.44 |
Fibonacci Pivot Point | $200.44 |
Simple Moving Averages | $195.10 - $239.14(5 indicators) |
Exponential Moving Averages | $197.42 - $234.74(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The session wrapped with RMD still elevated after a strong 4.24% gap versus yesterday. The session finished with relatively light trading in RMD, at 0.51× its average volume. Into the bell, robust sector gains of 2.65% helped fuel broader buying interest.
Trading Volume
0
vs S&P 500 Today
Strong Outperformance
+8.86%
52-Week Position
Lower range
25.9%
Updated: July 2, 2026 at 20:13 UTC
Quote Summary
RMD Headlines
RTX, P&G and ResMed in Focus After New Updates
April 20, 2026
Institutions Shift Positions in Major Blue-Chip Stocks
April 17, 2026
2025 Valuation Insights: Spotify, Aker BP, and Key Growth Stocks
December 7, 2025